Literature DB >> 28391428

Do clinical outcomes correlate with bone density after open reduction and internal fixation of tibial plateau fractures.

Elizabeth Gausden1, Matthew R Garner2, Peter D Fabricant1, Stephen J Warner1, Andre D Shaffer1, Dean G Lorich1,3.   

Abstract

INTRODUCTION: The operative management of tibial plateau fractures in elderly patients has historically led to inconsistent results, and these clinical outcomes were thought to be associated with poor bone quality often in elderly patients. The goal of this study was to investigate the relationship between bone density and subjective clinical outcome scores after open reduction and internal fixation of tibial plateau fractures.
MATERIALS AND METHODS: This is a retrospective cohort study from a single-surgeon conducted at an Academic, Level 1 Trauma Center. A preoperative computed tomography (CT) scan was obtained for all patients. Bone density of the distal femur was quantified with Hounsfield units (HU) as measured on axial CT scans. Inter-rater reliability of HU measurements was assessed using interclass correlation coefficients. Regression models controlling for age were used to identify relationships between bone density (HU) and the following variables: articular subsidence and 1-year subjective clinical outcomes scores [Knee Outcome Survey Activities of Daily Living Scale (KOS-ADLS), and Short-Form-36 (SF-36) physical and mental component scores (PCS, MCS)].
RESULTS: Sixty-one patients with a mean age of 59.3 years (range 27-85 years) and a minimum of 12 months of clinical follow-up were included in the study. The majority of the fractures (32 of 61) were classified as Schatzker II tibial plateau fractures, and there were 13 Schatzker V fractures, 11 Schatzker VI fractures, 2 Schatzker IV fractures and 1 Schatzker 1 fracture. HU measurements demonstrated an almost perfect inter-observer reliability (ICC = 0.97). Age was negatively correlated with HU measurements (r = -0.51, p < 0.001), and using a geriatric cut-off of 65 years of age, the geriatric group had a lower mean HU compared to the non-geriatric group (78.2 versus 114.8, p = 0.018). There was no significant relationship between bone quality, as assessed by distal femoral HU, and any subjective clinical outcome score.
CONCLUSIONS: Inferior bone mineral density alone does not appear to affect clinical outcomes 1 year postoperatively when bone grafting is used to restore osseous voids. Poor bone quality should not be used as an indication for non-operative management of tibial plateau fractures.

Entities:  

Keywords:  Bone quality; Hounsfield units; Postoperative outcomes

Mesh:

Year:  2017        PMID: 28391428     DOI: 10.1007/s00402-017-2679-x

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  4 in total

1.  Supination External Rotational Ankle Fracture Injury Pattern Correlation With Regional Bone Density.

Authors:  Stephen J Warner; Elizabeth B Gausden; Ashley E Levack; Dean G Lorich
Journal:  Foot Ankle Int       Date:  2018-12-21       Impact factor: 2.827

2.  Tibial plateau fractures in the elderly have clinical outcomes similar to those in younger patients.

Authors:  Meghan Maseda; Sanjit Konda; Philipp Leucht; Abishek Ganta; Raj Karia; Kenneth Egol
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-09-17

3.  Radiographic and clinical outcome of tibial plateau fractures treated with bone allograft.

Authors:  Sarah Meiser; Rohit Arora; Johannes Petersen; Alexander Keiler; Michael C Liebensteiner; Johannes Dominikus Pallua; Alexander Wurm
Journal:  Arch Orthop Trauma Surg       Date:  2022-05-10       Impact factor: 2.928

4.  The performance of PROMIS computer adaptive testing for patient-reported outcomes in hip fracture surgery: a pilot study.

Authors:  Aleksey Dvorzhinskiy; Elizabeth B Gausden; Ashley E Levack; Benedict U Nwachukwu; Joseph Nguyen; Naomi E Gadinsky; David S Wellman; Dean G Lorich
Journal:  Arch Orthop Trauma Surg       Date:  2021-01-02       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.